Sun H, et al. Diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.
Google Scholar
Harding JL, et al. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62:3–16.
Google Scholar
Rasmi Y, et al. Herbal-based therapeutics for diabetic patients with SARS-Cov-2 infection. Mol Biol Rep. 2024;51(1):316.
Google Scholar
Shah KB, et al. Maternal diabetes alters MicroRNA expression in fetal exosomes, human umbilical vein endothelial cells and placenta. Pediatr Res. 2021;89(5):1157–63.
Google Scholar
Cade WT. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther. 2008;88(11):1322–35.
Google Scholar
Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related complications. Phys Ther. 2008;88(11):1254–64.
Google Scholar
Ho RC, et al. Regulation of IκB kinase and NF-κB in contracting adult rat skeletal muscle. Am J Physiology-Cell Physiol. 2005;289(4):C794–801.
Google Scholar
Wang Y, et al. MicroRNA-126 attenuates palmitate-induced apoptosis by targeting TRAF7 in HUVECs. Mol Cell Biochem. 2015;399:123–30.
Google Scholar
Tang S-t, et al. MicroRNA-126 suppresses inflammation in endothelial cells under hyperglycemic condition by targeting HMGB1. Vascul Pharmacol. 2017;88:48–55.
Google Scholar
Poissonnier L, et al. miR126-5p repression of ALCAM and SetD5 in endothelial cells regulates leucocyte adhesion and transmigration. Cardiovascular Res. 2014;102(3):436–47.
Google Scholar
Brownrigg JR, et al. The association of ulceration of the foot with cardiovascular and all-cause mortality in patients with diabetes: a meta-analysis. Diabetologia. 2012;55(11):2906–12.
Google Scholar
Harding JL, et al. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62(1):3–16.
Google Scholar
Xi T, et al. MicroRNA-126-3p attenuates blood-brain barrier disruption, cerebral edema and neuronal injury following intracerebral hemorrhage by regulating PIK3R2 and Akt. Biochem Biophys Res Commun. 2017;494(1–2):144–51.
Google Scholar
Li P, et al. 17 β-estradiol enhances vascular endothelial Ets-1/miR-126-3p expression: the possible mechanism for Attenuation of atherosclerosis. J Clin Endocrinol Metabolism. 2017;102(2):594–603.
Google Scholar
Zhou J, et al. Regulation of vascular smooth muscle cell turnover by endothelial cell–secreted microRNA-126: role of shear stress. Circul Res. 2013;113(1):40–51.
Google Scholar
Li H, et al. Research progress on the pathogenesis of diabetic retinopathy. BMC Ophthalmol. 2023;23(1):372.
Google Scholar
Alicic RZ, et al. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrology: CJASN. 2017;12(12):2032–45.
Google Scholar
Afkarian M, et al. Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrology: JASN. 2013;24(2):302–8.
Google Scholar
Safavi K, et al. Mitigating diabetic cardiomyopathy: the synergistic potential of sea Buckthorn and Metformin explored via bioinformatics and chemoinformatics. Biology. 2025;14(4):361.
Google Scholar
Dal Canto E, et al. Diabetes as a cardiovascular risk factor: an overview of global trends of macro and micro vascular complications. Eur J Prev Cardiol. 2019;26(2suppl):25–32.
Google Scholar
Feng J, Xing W, Xie L. Regulatory roles of MicroRNAs in diabetes. Int J Mol Sci. 2016;17(10):1729.
Google Scholar
Fish JE, et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell. 2008;15(2):272–84.
Google Scholar
Osipova J, et al. Diabetes-associated MicroRNAs in pediatric patients with type 1 diabetes mellitus: a cross-sectional cohort study. J Clin Endocrinol Metabolism. 2014;99(9):E1661–5.
Google Scholar
Davis PJ, Leinung M, Mousa SA. MicroRNAs and angiogenesis, in Anti-Angiogenesis strategies in cancer therapeutics. Elsevier; 2017. pp. 69–84.
Pan Q, et al. MicroRNA-126 priming enhances functions of endothelial progenitor cells under physiological and hypoxic conditions and their therapeutic efficacy in cerebral ischemic damage. Stem Cells Int. 2018;2018(1):2912347.
Google Scholar
Barutta F, et al. MicroRNA-126 and micro-/macrovascular complications of type 1 diabetes in the EURODIAB prospective complications study. Acta Diabetol. 2017;54:133–9.
Google Scholar
Wang L et al. Role of MicroRNAs in diabetic foot ulcers: mechanisms and possible interventions. Diabetes Res Clin Pract, 2024: p. 111858.
Association AD. Standards of medical care in diabetes. Diabetes Care. 2005;28(1):S4.
Google Scholar
Scherm MG, Daniel C. miRNA-mediated immune regulation in islet autoimmunity and type 1 diabetes. Front Endocrinol. 2020;11:606322.
Google Scholar
Angelescu MA, et al. MiRNAs as biomarkers in diabetes: moving towards precision medicine. Int J Mol Sci. 2022;23(21):12843.
Google Scholar
Assmann TS, et al. MicroRNA expression profiles and type 1 diabetes mellitus: systematic review and bioinformatic analysis. Endocr Connections. 2017;6(8):773–90.
Google Scholar
Stumvoll M, Goldstein BJ, Van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005;365(9467):1333–46.
Google Scholar
Ghoshal K. Exosomal RNA in type 2 diabetes mellitus and other metabolic diseases, in Exosomal RNA. 2024, Elsevier. pp. 135–165.
Joglekar MV, Joglekar VM, Hardikar AA. Expression of islet-specific MicroRNAs during human pancreatic development. Gene Expr Patterns. 2009;9(2):109–13.
Google Scholar
Kim M, Zhang X. The profiling and role of MiRNAs in diabetes mellitus. J Diabetes Clin Res. 2019;1(1):5.
Google Scholar
He X, et al. Emerging roles of Exosomal MiRNAs in diabetes mellitus. Clin Translational Med. 2021;11(6):e468.
Google Scholar
Liu Z-N, et al. MiRNAs in gestational diabetes mellitus: potential mechanisms and clinical applications. J Diabetes Res. 2021;2021(1):4632745.
Google Scholar
Rice GE, et al. The effect of glucose on the release and bioactivity of exosomes from first trimester trophoblast cells. J Clin Endocrinol Metabolism. 2015;100(10):E1280–8.
Google Scholar
Chen SH, Liu XN, Peng Y. MicroRNA-351 eases insulin resistance and liver gluconeogenesis via the PI3K/AKT pathway by inhibiting FLOT2 in mice of gestational diabetes mellitus. J Cell Mol Med. 2019;23(9):5895–906.
Google Scholar
Mageed SSA, et al. The role of MiRNAs in insulin resistance and diabetic macrovascular complications–A review. Int J Biol Macromol. 2023;230:123189.
Google Scholar
Ismail A, et al. MiRNAs as cornerstones in diabetic microvascular complications. Mol Genet Metab. 2023;138(1):106978.
Google Scholar
American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes. Diabetes care. 2024;47(Suppl 1):S20–S42.
Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 2020;98(4S):S1–115.
Ikizler TA, et al. KDOQI clinical practice guideline for nutrition in CKD: 2020 update. Am J Kidney Diseases: Official J Natl Kidney Foundation. 2020;76(3 Suppl 1):S1–107.
Google Scholar
Ma Y, et al. Roles of physical exercise-induced MiR-126 in cardiovascular health of type 2 diabetes. Diabetol Metab Syndr. 2022;14(1):169.
Google Scholar
Pordzik J, et al. MiR-126 is an independent predictor of long-term all-cause mortality in patients with type 2 diabetes mellitus. J Clin Med. 2021;10(11):2371.
Google Scholar
De Rosa S, et al. Transcoronary concentration gradients of Circulating MicroRNAs in heart failure. Eur J Heart Fail. 2018;20(6):1000–10.
Google Scholar
Naderi R, et al. The effect of Garlic and voluntary exercise on cardiac angiogenesis in diabetes: the role of MiR-126 and MiR-210. Arquivos Brasileiros De Cardiologia. 2018;112:p154–162.
Zhang T, et al. Plasma miR-126 is a potential biomarker for early prediction of type 2 diabetes mellitus in susceptible individuals. Biomed Res Int. 2013;2013(1):761617.
Google Scholar
Al-Kafaji G, et al. Decreased expression of Circulating microRNA-126 in patients with type 2 diabetic nephropathy: A potential blood-based biomarker. Experimental Therapeutic Med. 2016;12(2):815–22.
Google Scholar
Schober A, et al. MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat Med. 2014;20(4):368–76.
Google Scholar
Baroni MG, et al. A common mutation in the insulin receptor substrate-1 gene is a genetic marker for the insulin resistance syndrome in patients with coronary artery disease. Arteriosclerosis, Thrombosis, And Vascular Biology; 1999;19(12):2975–80.
Cook SA, et al. Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction. Eur Heart J. 2010;31(1):100–11.
Google Scholar
Tao H, et al. MiR-126 suppresses the glucose-stimulated proliferation via IRS-2 in INS-1 β cells. PLoS ONE. 2016;11(2):e0149954.
Google Scholar
Arevalo-Martinez M, et al. miR-126 contributes to the epigenetic signature of diabetic vascular smooth muscle and enhances antirestenosis effects of Kv1. 3 blockers. Mol Metabolism. 2021;53:101306.
Google Scholar
Witkowski M, et al. Micro–RNA-126 reduces the blood thrombogenicity in diabetes mellitus via targeting of tissue factor. Arterioscler Thromb Vasc Biol. 2016;36(6):1263–71.
Google Scholar
Suresh Babu S, et al. MicroRNA-126 overexpression rescues diabetes-induced impairment in efferocytosis of apoptotic cardiomyocytes. Sci Rep. 2016;6(1):36207.
Google Scholar
Rawal S, et al. Down-regulation of proangiogenic microRNA-126 and microRNA-132 are early modulators of diabetic cardiac microangiopathy. Cardiovascular Res. 2017;113(1):90–101.
Google Scholar
Siwaponanan P, et al. Increased small extracellular vesicle levels and decreased miR-126 levels associated with atrial fibrillation and coexisting diabetes mellitus. Clin Cardiol. 2023;46(11):1326–36.
Google Scholar
Vithian K, Hurel S. Microvascular complications: pathophysiology and management. Clin Med. 2010;10(5):505.
Google Scholar
Fourdinier O, et al. Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients. Sci Rep. 2019;9(1):4477.
Google Scholar
Liu Y, et al. Stability of miR-126 in urine and its potential as a biomarker for renal endothelial injury with diabetic nephropathy. Int J Endocrinol. 2014;2014(1):393109.
Google Scholar
Dimuccio V, et al. Upregulation of miR145 and miR126 in EVs from renal cells undergoing EMT and urine of diabetic nephropathy patients. Int J Mol Sci. 2022;23(20):12098.
Google Scholar
Wonnacott A, et al. MicroRNAs and their delivery in diabetic fibrosis. Adv Drug Deliv Rev. 2022;182:114045.
Google Scholar
Pramanik S et al. Decreased levels of miR-126 and miR-132 in plasma and vitreous humor of non-proliferative diabetic retinopathy among subjects with type-2 diabetes mellitus. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 2022: pp. 345–358.
Sanguineti R, et al. miR-126 mimic counteracts the increased secretion of VEGF‐A induced by high glucose in ARPE‐19 cells. J Diabetes Res. 2021;2021(1):6649222.
Google Scholar
Wang Y, Yan H. MicroRNA-126 contributes to Niaspan treatment induced vascular restoration after diabetic retinopathy. Sci Rep. 2016;6(1):26909.
Google Scholar
Qin L-L, et al. MicroRNA-126: a promising novel biomarker in peripheral blood for diabetic retinopathy. Int J Ophthalmol. 2017;10(4):530.
Google Scholar
Zhao W, et al. Mechanisms of MALAT1 regulating proliferative diabetic retinopathy via targeting miR-126-5p. Am J Translational Res. 2023;15(5):3279.
Google Scholar
Massignam ET, et al. Involvement of miR-126 rs4636297 and miR‐146a rs2910164 polymorphisms in the susceptibility for diabetic retinopathy: a case–control study in a type 1 diabetes population. Acta Ophthalmol. 2021;99(4):e461–9.
Google Scholar
Soliman AM, et al. Role of MicroRNA in proliferation phase of wound healing. Front Genet. 2018;9:38.
Google Scholar
Lyttle BD, et al. Effects of MicroRNAs on angiogenesis in diabetic wounds. Front Med. 2023;10:1140979.
Google Scholar
Wang S, Olson EN. AngiomiRs—key regulators of angiogenesis. Curr Opin Genet Dev. 2009;19(3):205–11.
Google Scholar
Zhang D et al. MicroRNA-126: a promising biomarker for angiogenesis of diabetic wounds treated with negative pressure wound therapy. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 2019: pp. 1685–1696.
Zhang J, et al. Increasing the miR-126 expression in the peripheral blood of patients with diabetic foot ulcers treated with maggot debridement therapy. J Diabetes Complicat. 2017;31(1):241–4.
Google Scholar
Li M, et al. Fabrication of hydroxyapatite/chitosan composite hydrogels loaded with exosomes derived from miR-126-3p overexpressed synovial mesenchymal stem cells for diabetic chronic wound healing. J Mater Chem B. 2016;4(42):6830–41.
Google Scholar
Wang L, et al. Effects of intensive glycemic control on serum exosome miR-126‐3p and miR‐125b‐1‐3p levels and wound healing in patients with diabetic ulcers. Evidence‐Based Complement Altern Med. 2023;2023(1):2523245.
Google Scholar
Xue W, et al. Hydrogen sulfide improves angiogenesis by regulating the transcription of pri-miR-126 in diabetic endothelial cells. Cells. 2022;11(17):2651.
Google Scholar
Tao S-C, et al. Chitosan wound dressings incorporating exosomes derived from microRNA-126-overexpressing synovium mesenchymal stem cells provide sustained release of exosomes and heal full-thickness skin defects in a diabetic rat model. Stem Cells Translational Med. 2017;6(3):736–47.
Google Scholar
Hong W, et al. Long noncoding RNA XIST promotes cell proliferation and migration in diabetic foot ulcers through the miR-126-3p/EGFR axis. Diabetol Metab Syndr. 2024;16(1):35.
Google Scholar
Lu W, et al. IFN-γ enhances the therapeutic efficacy of MSCs‐derived exosome via miR‐126‐3p in diabetic wound healing by targeting SPRED1. J Diabetes. 2024;16(1):e13465.
Google Scholar
Wang Y, Wu X. New perspectives and prospects of MicroRNA delivery in diabetic wound healing. Mol Pharmacol. 2024;106(2):84–91.
Google Scholar
Deka Dey A, et al. miRNA-encapsulated abiotic materials and biovectors for cutaneous and oral wound healing: biogenesis, mechanisms, and delivery nanocarriers. Bioeng Translational Med. 2023;8(1):e10343.
Google Scholar
Zheng Y, et al. MicroRNA-126 suppresses the proliferation and migration of endothelial cells in experimental diabetic retinopathy by targeting polo-like kinase 4. Int J Mol Med. 2021;47(1):151–60.
Google Scholar
Zernecke A, et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal. 2009;2(100):ra81–81.
Google Scholar
Ortega FJ, et al. Profiling of Circulating MicroRNAs reveals common MicroRNAs linked to type 2 diabetes that change with insulin sensitization. Diabetes Care. 2014;37(5):1375–83.
Google Scholar
Zampetaki A, et al. Plasma MicroRNA profiling reveals loss of endothelial miR-126 and other MicroRNAs in type 2 diabetes. Circul Res. 2010;107(6):810–7.
Google Scholar
Coulson DJ, et al. MiR-126, IL-7, CXCR1/2 receptors, inflammation and Circulating endothelial progenitor cells: the study on targets for treatment pathways in a model of subclinical cardiovascular disease (type 1 diabetes mellitus). J Translational Med. 2021;19:1–12.
Google Scholar
Meng S, et al. Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1. J Mol Cell Cardiol. 2012;53(1):64–72.
Google Scholar
Li Y, et al. Hyperglycemia and advanced glycation end products regulate miR-126 expression in endothelial progenitor cells. J Vasc Res. 2016;53(1–2):94–104.
Google Scholar
Lou Z, et al. The effects of microRNA-126 reduced inflammation and apoptosis of diabetic nephropathy through PI3K/AKT signalling pathway by VEGF. Arch Physiol Biochem. 2022;128(5):1265–74.
Google Scholar
Nie H, et al. Combining bioinformatics techniques to study diabetes biomarkers and related molecular mechanisms. Front Genet. 2020;11:367.
Google Scholar
Asgari M, et al. Interval training and Crataegus persica ameliorate diabetic nephropathy via miR-126/Nrf-2 mediated Inhibition of stress oxidative in rats with diabetes after myocardial ischemia-reperfusion injury. Biomed Pharmacother. 2022;153:113411.
Google Scholar
Fang S, et al. MicroRNA-126 inhibits cell viability and invasion in a diabetic retinopathy model via targeting IRS-1. Oncol Lett. 2017;14(4):4311–8.
Google Scholar
Yang W-Z, et al. MiR-126 overexpression inhibits high glucose-induced migration and tube formation of rhesus macaque choroid-retinal endothelial cells by obstructing VEGFA and PIK3R2. J Diabetes Complicat. 2017;31(4):653–63.
Google Scholar
Li S-H, et al. Naringenin alleviates myocardial ischemia reperfusion injury by enhancing the myocardial miR-126-PI3K/AKT axis in streptozotocin-induced diabetic rats. Experimental Therapeutic Med. 2021;22(2):810.
Google Scholar
Cao D-w, et al. Upregulation of MiR-126 delays the senescence of human glomerular mesangial cells induced by high glucose via telomere-p53-p21-Rb signaling pathway. Curr Med Sci. 2018;38(5):758–64.
Google Scholar
Cao D, et al. Role of tea polyphenols in delaying hyperglycemia-induced senescence in human glomerular mesangial cells via miR-126/Akt–p53–p21 pathways. Int Urol Nephrol. 2019;51:1071–8.
Google Scholar
Qiu B, Qi X, Wang J. CircTLK1 downregulation attenuates high glucose-induced human mesangial cell injury by blocking the AKT/NF-κB pathway through sponging miR-126-5p/miR-204-5p. Biochem Genet. 2022;60(5):1471–87.
Google Scholar
Rezk NA, Sabbah NA, Saad MS. Role of MicroRNA 126 in screening, diagnosis, and prognosis of diabetic patients in Egypt. IUBMB Life. 2016;68(6):452–8.
Google Scholar
Liu Y, et al. The role of Circulating microRNA-126 (miR-126): a novel biomarker for screening prediabetes and newly diagnosed type 2 diabetes mellitus. Int J Mol Sci. 2014;15(6):10567–77.
Google Scholar
Castaño C, et al. Obesity-associated Exosomal MiRNAs modulate glucose and lipid metabolism in mice. Proc Natl Acad Sci. 2018;115(48):12158–63.
Google Scholar
Wang S, et al. The endothelial-specific MicroRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell. 2008;15(2):261–71.
Google Scholar
Hadi HA, Suwaidi JA. Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag. 2007;3(6):853–76.
Google Scholar
Venkat P, et al. MiR-126 mediates brain endothelial cell exosome treatment–induced neurorestorative effects after stroke in type 2 diabetes mellitus mice. Stroke. 2019;50(10):2865–74.
Google Scholar
Hu Y, et al. Identification of miR-126 knockdown mouse and the change of blood glucose. Zhong Nan Da Xue Xue bao. Yi Xue ban = journal of central South university. Med Sci. 2015;40(1):12–7.
He Y, et al. Relationship of miRNA–126 and miRNA–122 expression with type 2 diabetes mellitus and related glucose metabolism parameters: A systematic review and meta–analysis. Experimental Therapeutic Med. 2022;24(5):652.
Google Scholar
Wang X, et al. Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the Exosomal transfer of miR-320 into endothelial cells. J Mol Cell Cardiol. 2014;74:139–50.
Google Scholar
Zhang T, Li L, Shang Q, Lv C, Wang C, Su B. Circulating miR-126 is a potential biomarker to predict the onset of type 2 diabetes mellitus in susceptible individuals. Biochem Biophys Res Commun. 2015;463(1–2):60–3.
Google Scholar
Giannella A, et al. Circulating levels and characterization of microparticles in patients with different degrees of glucose tolerance. Cardiovasc Diabetol. 2017;16:1–10.
Google Scholar
Zeinali F, et al. Circulating microRNA-122, microRNA-126-3p and microRNA-146a are associated with inflammation in patients with pre-diabetes and type 2 diabetes mellitus: A case control study. PLoS ONE. 2021;16(6):e0251697.
Google Scholar
Ryu HS, et al. The induction of MicroRNA targeting IRS-1 is involved in the development of insulin resistance under conditions of mitochondrial dysfunction in hepatocytes. PLoS ONE. 2011;6(3):e17343.
Google Scholar
Ghoshal K, Bhattacharyya M. Overview of platelet physiology: its hemostatic and nonhemostatic role in disease pathogenesis. Sci World J. 2014;2014(1):781857.
Heishima K, et al. Circulating microRNA-214 and-126 as potential biomarkers for canine neoplastic disease. Sci Rep. 2017;7(1):2301.
Google Scholar
Cui S, et al. MiRTarBase 2025: updates to the collection of experimentally validated microRNA–target interactions. Nucleic Acids Res. 2025;53(D1):D147–56.
Google Scholar
Kanehisa M, Furumichi M, Sato Y, Matsuura Y. and Ishiguro-Watanabe, M KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672–D677 (2025). https://doi.org/10.1093/nar/gkae909
Google Scholar
Szklarczyk D, et al. The STRING database in 2025: protein networks with directionality of regulation. Nucleic Acids Res. 2025;53(D1):D730–7.
Google Scholar
Franz M, et al. Cytoscape. Js 2023 update: a graph theory library for visualization and analysis. Bioinformatics. 2023;39(1):btad031.
Google Scholar
Chin C-H, et al. CytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8:1–7.
Google Scholar
Zhang G, et al. Unraveling the mystery of cancer metabolism in the genesis of tumor-initiating cells and development of cancer. Biochim Et Biophys Acta (BBA)-Reviews Cancer. 2013;1836(1):49–59.
Google Scholar
Lu S, Cai J. Targeting therapy of PI3K/AKT signaling pathway via non-coding RNAs in diabetic retinopathy. Naunyn-Schmiedeberg’s Archives of Pharmacology; 2025. pp. 1–12.
Qing M, et al. Study on effect of pancreatic kininogenase on diabetic nephropathy-induced fibrosis via Notch1/Hes1/Pten/Akt signaling pathway. BMC Nephrol. 2025;26(1):196.
Google Scholar
Saxena AK, et al. PPARγ and AKt gene modulation following Pregabalin and Duloxetine combination for painful diabetic polyneuropathy. Pain Manage. 2024;14(5–6):273–81.
Google Scholar
Gurzov EN, Eizirik DL. Bcl-2 proteins in diabetes: mitochondrial pathways of β-cell death and dysfunction. Trends Cell Biol. 2011;21(7):424–31.
Google Scholar
Peng Y, et al. Resveratrol alleviates reactive oxygen species and inflammation in diabetic retinopathy via SIRT1/HMGB1 pathway-mediated ferroptosis. Toxicol Appl Pharmcol. 2025;495:117214.
Google Scholar
Mai H, et al. Carnosic acid attenuates diabetic retinopathy via the SIRT1 signaling pathway: neuroprotection and endothelial cell preservation. Am J Translational Res. 2025;17(3):2293.
Google Scholar
Yang Y-F et al. Molecular mechanisms of Buqing granule for the treatment of diabetic retinopathy: Network pharmacology analysis and experimental validation. World Journal of Diabetes. 2024;15(9):1942.
Taheri M, et al. Expression profile of MicroRNAs in bladder cancer and their application as biomarkers. Biomed Pharmacother. 2020;131:110703.
Google Scholar
Qian H, et al. Decoding the promise and challenges of miRNA-Based cancer therapies: an essential update on miR-21, miR-34, and miR-155. Int J Med Sci. 2024;21(14):2781.
Google Scholar
Takahashi P, et al. MicroRNA expression profiling and functional annotation analysis of their targets in patients with type 1 diabetes mellitus. Gene. 2014;539(2):213–23.
Google Scholar
Hezova R, et al. microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients. Cell Immunol. 2010;260(2):70–4.
Google Scholar
Cui X, et al. Change in Circulating MicroRNA profile of obese children indicates future risk of adult diabetes. Metabolism. 2018;78:95–105.
Google Scholar
Nielsen LB, et al. Circulating levels of MicroRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta‐cell function and glycaemic control during disease progression. J Diabetes Res. 2012;2012(1):896362.
Seyhan AA, et al. Pancreas-enriched MiRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study. Sci Rep. 2016;6(1):31479.
Google Scholar
Erener S, et al. Profiling of Circulating MicroRNAs in children with recent onset of type 1 diabetes. JCI Insight. 2017;2(4):e89656.
Google Scholar
Tian C, et al. Cross-talks between MicroRNAs and mRNAs in pancreatic tissues of streptozotocin-induced type 1 diabetic mice. Biomedical Rep. 2015;3(3):333–42.
Google Scholar
Delic D, et al. Characterization of micro-RNA changes during the progression of type 2 diabetes in Zucker diabetic fatty rats. Int J Mol Sci. 2016;17(5):665.
Google Scholar
116. Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. and Ishiguro-Watanabe, M.; KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672-D677 (2025). https://doi.org/10.1093/nar/gkae909
